Abbott is now aiming to recover the baby-formula market share that it lost
admin Abbott Laboratories ABT, -1.55% is focused on recovering its position in the baby-formula market in…
Read MoreFinancial Performance
Netflix isn’t a simple story anymore, but it is almost back to a $100 billion valuation
Netflix Inc. sees a more upbeat path ahead after two straight quarters of subscriber losses,…
Read MoreChip stocks rally despite an ominous forecast, as U.S. semiconductor funding bill advances in Senate
Chip stocks rallied Wednesday after the Senate moved closer to greenlighting more than $50 billion…
Read MoreIBM stock drops despite ‘solid’ results, as some analysts worry about slowing growth and rising risks
International Business Machines Corp. reported better-than-expected second-quarter results after the stock market closed on Monday,…
Read MoreBernstein still sees more pain ahead for stocks, until capitulation triggers bonafide rally next year
How bad is the mood out there right now? Try max bearish. So said Bank…
Read MoreVolvo Car expects supply constraints to continue weighing on sales into 3Q
STOCKHOLM–Volvo Car AB said Wednesday that supply constraints and coronavirus-related lockdowns in China hit retail…
Read MoreASML Holding reports net profit rise, but lowers revenue growth guidance
ASML Holding NV said Wednesday that second-quarter net profit rose, but lowered its full-year revenue…
Read MoreAkzo Nobel sees big 2Q net income miss as it books higher costs
Akzo Nobel NV on Wednesday reported a more-than halved second-quarter net profit–missing market forecasts–as it…
Read MoreAkzo Nobel sees big 2Q net income miss as it books higher costs
Akzo Nobel NV on Wednesday reported a more-than halved second-quarter net profit–missing market forecasts–as it…
Read More
Opinion: Almost all the economic numbers line up: A U.S. recession is likely
The United States is perilously close to falling into a recession, despite the reassurances of…
Read More